Clover Health Investments Corp. Class A (CLOV)

Over the past six months, Clover Health's stock has been impacted by several events. In August 2025, the company released its second-quarter 2025 financial results, reporting growth in membership and revenue, alongside sustained Adjusted EBITDA profitability, and there was also insider selling activity. In early February 2026, the stock reached a new 52-week low, analysts decreased price targets, and news regarding flat Medicare Advantage rates was noted. Despite these challenges, Clover Health announced a 53% year-over-year increase in Medicare Advantage membership for the 2026 plan year, reaching approximately 153,000 members as of January 1, 2026, and anticipates achieving its first-ever full-year GAAP Net Income profitability in 2026. The third-quarter 2025 earnings report indicated an earnings per share (EPS) miss, even though the company exceeded revenue expectations. On February 5, 2026, a buy signal was issued from a pivot bottom point, and the stock rose by 4.41% on February 6, 2026, although it continues to hold sell signals from both short and long-term Moving Averages.

Specific information regarding the demand seasonality for Clover Health Investments Corp.'s products and services was not directly available in the provided search results. While some financial platforms offer tools to analyze market seasonality, direct data for Clover Health's demand patterns was not found.

Clover Health Investments Corp. is a physician-enablement technology company in the healthcare sector, focusing on providing healthcare access to Medicare beneficiaries. Its core offerings include the Clover Assistant software platform and Medicare Advantage plans. The Clover Assistant aggregates patient data to aid physicians in clinical decision-making and improve health outcomes. Clover Health provides PPO and HMO plans to MA members and extends its technology platform to healthcare providers outside its MA plans via Counterpart Health, Inc.

Clover Health has a geographic footprint across several U.S. states, serving both urban and rural markets in regions such as the Northeast, Southeast, and Midwest. As of August 2021, the company had beneficiaries in 11 states: Arizona, Georgia, Kansas, New Jersey, New York, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, and Vermont.

Information specifically detailing events that have affected Clover Health Investments Corp.'s brand reputation in the past year (February 2025 to February 2026) was not explicitly found in the search results. Analyst ratings for the company are mixed, with a consensus "Hold" rating from five brokerages.

Clover Health Investments Corp. has a significant number of institutional owners, including BlackRock, Inc., Vanguard Group Inc, Geode Capital Management, Llc, and State Street Corp. Institutional ownership in CLOV saw an increase in the second quarter of 2025.